Faron Pharmaceuticals Oy FARN.L
GBX36.58
Last Updated: Oct 09, 12:00 AM·LSE
Pricing for GB stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Faron Pharmaceuticals Oy Stock Halal?
Shariah Compliance Analysis of FARN.L Stock
United Kingdom Health Care Micro Cap No. As of October 2026, Faron Pharmaceuticals Oy (FARN.L) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Faron Pharmaceuticals Oy does not pass Musaffa's business and financial screening criteria.
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company, which engages in the development of drugs to treat acute respiratory distress syndrome. The company is headquartered in Turku, Lansi-Suomen and currently employs 33 full-time employees. The company went IPO on 2015-11-17. The firm has three drug candidates all based on mastering immune modulation and, as a result, tackling unmet needs in cancer, preventing organ damage and treating blood count abnormalities. The firm's goal is to build future immunotherapy, i.e., to bring new treatments to patients by affecting the immune system. Faron’s drug candidate, Traumakine, is a drug developed by the Company to prevent multi-organ damage and excessive inflammatory responses. Another drug candidate, Haematokine, promotes the expansion of bone marrow stem cells. The company is being developed, e.g., for the treatment of chemotherapyinduced neutropenia (CIN). In neutropenia patients have less blood cells called neutrophils than normal due to cancer treatment.
FARN.L Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Faron Pharmaceuticals Oy is classified as not halal.
NOT HALALFaron Pharmaceuticals Oy (FARN.L) Chart
Fetching Price Chart...
Financial Metrics & Statements of Faron Pharmaceuticals Oy (FARN.L)
FAQ's for Faron Pharmaceuticals Oy (FARN.L)
- As of October 2026, Faron Pharmaceuticals Oy FARN.L is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Faron Pharmaceuticals Oy using these criteria to determine its compliance status.
- Muslim investors may consider investing in Faron Pharmaceuticals Oy if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Faron Pharmaceuticals Oy by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Faron Pharmaceuticals Oy may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Faron Pharmaceuticals Oy on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Faron Pharmaceuticals Oy (FARN.L)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
